https://www.selleckchem.com/pr....oducts/pirtobrutinib
0002). EZH2 expression was positively correlated with tumor stage (P less then 0.0001; r=0.504), and multiple comparison analysis revealed that the highest expression of EZH2 was detected in samples staged pT4 (P=0.0001). SMYD3 expression was detected in all thyroid cancer samples and in 96.7% of healthy thyroid tissues; notably, the expression levels were similar in both groups. In addition, there was no correlation between SMYD3 expression and the aggressiveness of papillary thyroid cancer. In conclusion, overexpression
Gefällt mir
Kommentar
Teilen
